The World Health Organization (WHO) has declared an unusually large-scale Ebola outbreak spreading across the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern (PHEIC).
According to the latest data, 336 suspected and 10 laboratory-confirmed cases have already been recorded in the region, 88 of which resulted in fatalities. The disease has already crossed the Congolese border—two cases, including one death, were detected in Kampala, the capital of neighboring Uganda.
Members of an American humanitarian mission operating in the outbreak zone, including a family with children, may have been in contact with infected individuals. According to the White House, emergency medical evacuation is already being planned for at least one American who has already exhibited symptoms of the disease, in order to place them under quarantine within the United States. The CDC is actively working on the safe evacuation of citizens and deploying additional forces to the area.
Why is this strain particularly dangerous?
Infectious disease specialists state that the current outbreak will be particularly difficult to contain because it is caused by the Bundibugyo virus—a specific Ebola strain for which there is currently no approved vaccine or treatment. Existing FDA-approved therapies (Inmazeb and Ebanga) work only against the classic Zaire Ebola strain. Consequently, medics are entirely dependent on prevention, contact tracing, quarantine, and supportive intensive care (such as rehydration).
The disease is not airborne (unlike coronavirus) and is transmitted only through direct contact with the bodily fluids of an infected person, which is why the CDC states that the risk to the global public remains low at this stage. However, the Bundibugyo strain, which carries a mortality rate of approximately 50%, is extremely hazardous, and an individual becomes contagious only after the onset of symptoms (fever, body aches, diarrhea, vomiting, unexplained bleeding).
Risks
According to epidemiologist Anne Rimoin (UCLA), the geographic footprint of the infection significantly complicates containment efforts. People in the region constantly migrate for work or trade, and the spread of the virus to major urban centers—such as Uganda’s capital, Kampala, with its extensive bus networks and crowded markets—exacerbates the situation.
The World Health Organization points to additional risks, including a war-driven humanitarian crisis, weak laboratory infrastructure, and public mistrust. In response to the unfolding situation, the Africa CDC, together with donors and pharmaceutical companies, has already begun coordinating an emergency action plan.
